spec sheet11 rows
DHEA sulfate (DHEAS) is the 3-beta sulfate ester of dehydroepiandrosterone and the most abundant circulating steroid in the human body, present in plasma at concentrations roughly a thousandfold higher than unconjugated DHEA. Synthesized principally in the zona reticularis of the adrenal cortex, it functions as a stable, long-lived reservoir that is interconverted with DHEA and supplies a precursor pool for downstream androgens and estrogens. Within the nervous system it is classified as a neurosteroid (a steroid synthesized in or acting directly upon nervous tissue); it acts as an agonist at the sigma-1 receptor (an intracellular chaperone protein), a positive modulator of the NMDA receptor (a glutamate-gated excitatory ion channel), and a negative allosteric modulator of the GABA-A receptor (the brain's principal inhibitory ion channel), giving it a net excitatory, pro-cognitive neuromodulatory profile. Circulating concentrations fall markedly with age, a decline termed adrenopause that has made DHEAS a widely studied biomarker of adrenal function, cognitive aging, and longevity.
- Enhances memory consolidation and retention in animal models, an effect tied to sigma-1 activation and NMDA potentiation
- Protects hippocampal neurons against glutamate excitotoxicity and amyloid-beta toxicity in preclinical studies
- Supports neurite outgrowth and neurodevelopment through interactions with microtubule-associated protein 2 and neurotrophin signaling
- Serves as a precursor reservoir for androgens and estrogens, buffering the hormonal decline that accompanies aging
- Acts as an excitatory, non-sedating neurosteroid associated with alertness and mood support
- Exhibits antiglucocorticoid and anti-inflammatory activity that may soften chronic stress effects
- Low levels mark biological aging, making restoration of DHEAS a target of longevity research
- Acne and oily skin driven by androgenic metabolites
- Hirsutism (excess facial or body hair) and scalp hair thinning, especially in women
- Voice deepening in women at higher doses
- Breast tenderness and other estrogenic effects
- Potential stimulation of hormone-sensitive cancers of the breast, ovary, uterus, or prostate
- Possible insomnia or overstimulation owing to its excitatory neurosteroid profile
Overview
The founding neurosteroid and the body's most abundant circulating steroid; a sigma-1 agonist and excitatory GABA-A/NMDA modulator that serves as the stable sulfated reservoir of DHEA, distinct from DHEA itself.
- DHEAS is the single most abundant steroid hormone in human circulation, present at roughly one thousand times the concentration of free DHEA and far exceeding cortisol or testosterone.
- The very concept of the neurosteroid was born from DHEAS; Baulieu's team found that brain levels of DHEAS remained high after the adrenal glands and gonads were removed, proving the nervous system makes and stores steroids on its own.
- Unlike calming neurosteroids such as allopregnanolone that open GABA-A channels, DHEAS blocks them while simultaneously boosting NMDA signaling, making it one of the few endogenous excitatory neurosteroids.
- Because its charged sulfate group blocks passive entry, DHEAS must be ferried across the blood-brain barrier by dedicated transporter proteins rather than simply diffusing in.
Mechanism
DHEAS is formed when dehydroepiandrosterone is conjugated at its 3-beta hydroxyl group with a sulfate group by the enzyme hydroxysteroid sulfotransferase SULT2A1, which uses 3'-phosphoadenosine-5'-phosphosulfate (PAPS, the universal cellular sulfate donor) as the sulfate source; this reaction occurs chiefly in the adrenal zona reticularis and the liver. The step is reversible within tissue: steroid sulfatase (STS, also called arylsulfatase C) hydrolyzes DHEAS back to free DHEA, establishing a dynamic sulfation cycle in which DHEAS behaves as a large, slowly exchanging reservoir. Because the ionized sulfate group makes the molecule hydrophilic, DHEAS crosses the poorly by passive diffusion and instead depends on carrier-mediated transport by organic anion transporting polypeptides (OATPs) and the organic solute transporter OSTalpha/OSTbeta. Upstream, DHEA itself derives from cholesterol through pregnenolone and 17-hydroxypregnenolone by the sequential action of the cholesterol side-chain cleavage enzyme (CYP11A1) and 17-alpha-hydroxylase/17,20-lyase (CYP17A1), and it serves as the common precursor for androstenedione, testosterone, and, through the enzyme aromatase, estrogens.
At the level of membrane signaling, DHEAS and DHEA behave as classic excitatory neurosteroids. They act as agonists at the sigma-1 receptor, a -operated chaperone located at the interface between the endoplasmic reticulum and mitochondria; structural and pharmacological studies confirm direct binding of these steroids within the sigma-1 ligand pocket. Through sigma-1 activation DHEAS potentiates responses mediated by the subtype of receptor, enhancing NMDA-evoked neuronal firing and neurotransmitter release in the , an action opposed by progesterone acting as a sigma-1 . In parallel, DHEAS is a non-competitive negative modulator of the -A receptor, reducing GABA-gated chloride flux; recent electrophysiology indicates that DHEAS, like pregnenolone sulfate, inhibits the receptor by stabilizing a nonconducting state. The combination of GABA-A inhibition with NMDA and sigma-1 potentiation renders DHEAS pro-excitatory, contrasting sharply with inhibitory neurosteroids such as allopregnanolone that enhance GABA-A currents. Additional targets include inhibition of the strychnine-sensitive glycine receptor and, for the desulfated DHEA form, direct binding to microtubule-associated protein 2 (MAP2, a cytoskeletal scaffolding protein) and to the neurotrophin receptors TrkA and p75, interactions linked to microtubule assembly, neurite outgrowth, and protection of neurons from apoptosis. DHEAS additionally exerts antiglucocorticoid and anti-inflammatory effects, and through local desulfation to DHEA it contributes to peripheral and central sex-steroid synthesis.
receptor fingerprint
Steroid sulfatase (STS)Substrate
Steroid sulfotransferase (SULT2A1)Product of sulfation
Sigma-1 receptorAgonist
Positive modulator
-A receptorNegative allosteric modulator
Microtubule-associated protein 2 (MAP2)Binder (via DHEA)
Glycine receptorInhibitor
TrkA and p75 neurotrophin receptorsIndirect activator (via DHEA)
Androgen and receptorsPrecursor reservoir
TRPM3 channelPartial agonist
Dosingtypical ranges, not medical advice
interested in protocols and clinical dosages? make an account to see them! ^_^
Safetyrisks and cautions, not medical advice
As an endogenous steroid present at high concentrations throughout life, DHEAS is not itself associated with acute toxicity, and short-term supplementation with its precursor DHEA is generally well tolerated in adults. The principal safety considerations arise from downstream conversion to androgens and estrogens: reported effects include acne, oily skin, hirsutism (excess hair growth), scalp hair thinning, and, less commonly, voice deepening in women, alongside possible estrogenic effects such as breast tenderness.
Because DHEAS feeds hormone-sensitive tissues, caution is advised in individuals with a history of breast, ovarian, uterine, or prostate cancer. Long-term human safety data are limited, and effects on cardiovascular risk factors and insulin sensitivity have been inconsistent across trials. Clinically, DHEAS measurement is used to evaluate adrenal androgen excess; markedly elevated levels can indicate an adrenal tumor or congenital adrenal hyperplasia, whereas very low levels accompany adrenal insufficiency.
History
Dehydroepiandrosterone was first isolated from human urine by Adolf Butenandt and colleagues in 1934, and its abundant sulfated ester was subsequently recognized as the dominant circulating form. DHEAS holds a central place in neuroendocrinology because it was the finding that concentrations of DHEAS and DHEA persist in the brain after removal of the adrenal glands and gonads that led Etienne-Emile Baulieu, in the early 1980s, to propose the concept of the neurosteroid, a steroid synthesized within the nervous system itself.
In 1984 Orentreich and colleagues documented the steep, age-related fall of DHEAS across the human lifespan, and by the 1990s the hormone had become a focus of intense interest as a possible marker and mediator of aging, spurring the popular but scientifically contested framing of DHEA as a fountain of youth. Passage of the Dietary Supplement Health and Education Act in the United States in 1994 made over-the-counter DHEA widely available, and large observational cohorts and randomized trials, including the French DHEAge Study, followed in an effort to define its physiological role.
Reputation
DHEAS occupies a dual reputation as both a foundational research molecule and a heavily marketed supplement ingredient. In the scientific literature it is esteemed as the archetypal neurosteroid and as a robust biomarker; low circulating DHEAS has been linked in prospective cohorts to frailty, cognitive decline, cardiovascular events, and mortality, though causation remains unproven. In the consumer market, DHEA, the route by which DHEAS is raised, is promoted for anti-aging, mood, libido, and cognitive benefits, claims that outrun the mixed and often modest results of controlled human trials. Within nootropic circles DHEAS is regarded as distinct from the inhibitory, calming neurosteroids; its sigma-1 and excitatory profile is associated with alertness, memory support, and neuroprotection rather than sedation.
Subjective profileweighing the evidence above
Not the thing to buy. DHEAS is a storage pool, and the practical lever is DHEA itself; even then the interesting brain effects are animal work while the androgenic downsides are not. Women in particular should weigh acne, hair thinning and voice changes first, and anyone with a hormone-sensitive cancer history should leave it alone.
Resources
This entry is here for reference.
Research
- 1986first citedA prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease
- 2025most active year11 papers
- 2026most recentAnti-aging effects of the adrenal androgens dehydroepiandrosterone and dehydroepiandrosterone s…
- 1.The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor
- 2.Receptor binding and electrophysiological effects of dehydroepiandrosterone sulfate, an antagonist of the GABAA receptor
- 3.The Sulfated Steroids Pregnenolone Sulfate and Dehydroepiandrosterone Sulfate Inhibit the α1β3γ2L GABA(A) Receptor by Stabilizing a Novel Nonconducting State.
- 4.Neurosteroids, via sigma receptors, modulate the [3H]norepinephrine release evoked by N-methyl-D-aspartate in the rat hippocampus
- 5.Potentiation of neuronal NMDA response induced by dehydroepiandrosterone and its suppression by progesterone: effects mediated via sigma receptors
- 6.Insight into binding of endogenous neurosteroid ligands to the sigma-1 receptor
- 7.Differential involvement of the sigma(1) (sigma(1)) receptor in the anti-amnesic effect of neuroactive steroids, as demonstrated using an in vivo antisense strategy in the mouse.
- 8.Neurosteroids as selective inhibitors of glycine receptor activity: structure-activity relationship study on endogenous androstanes and androstenes
- 9.Microtubule-associated protein 2 (MAP2) is a neurosteroid receptor
- 10.Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis
- 11.Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity
- 12.Dehydroepiandrosterone: a potential signalling molecule for neocortical organization during development
46 listed here; entry last updated August 2026
Reviews
My notesprivate to this device
FAQ
How is DHEAS different from DHEA?
DHEA is the free, active steroid, while DHEAS is its sulfated storage form. DHEAS circulates at roughly a thousandfold higher concentration and has a much longer half-life, so it acts as a stable reservoir that the body interconverts with DHEA as needed. Blood tests usually measure DHEAS because its levels stay steady throughout the day.
Is DHEAS excitatory or calming?
It is excitatory. DHEAS agonizes the sigma-1 receptor, potentiates NMDA glutamate receptors, and inhibits inhibitory GABA-A receptors, a combination that raises neuronal activity. This sets it apart from sedating neurosteroids such as allopregnanolone.
Can you take DHEAS as a supplement?
DHEAS itself is seldom sold; supplements provide DHEA, which the body sulfates into DHEAS. Oral DHEA can raise circulating DHEAS toward youthful levels, though human evidence for cognitive or anti-aging benefit is mixed, and it is banned in competitive sport.
Why do DHEAS levels matter with age?
DHEAS peaks in early adulthood and then falls steadily, a decline sometimes called adrenopause. Low DHEAS in older people has been associated in large studies with frailty, cognitive decline, and higher mortality, which is why it is studied as a biomarker of aging.
Does DHEAS work in the brain or only through hormones?
Both. As a neurosteroid it directly modulates sigma-1, NMDA, and GABA-A receptors in the brain, and it also serves as a precursor that is converted locally into androgens and estrogens. Its charged structure means it relies on transporter proteins to enter the brain.
Adverse effects
- Acne and oily skin driven by androgenic metabolites
- Hirsutism (excess facial or body hair) and scalp hair thinning, especially in women
- Voice deepening in women at higher doses
- Breast tenderness and other estrogenic effects
- Potential stimulation of hormone-sensitive cancers of the breast, ovary, uterus, or prostate
- Possible insomnia or overstimulation owing to its excitatory neurosteroid profile
Notes and cautions
- Prohibited in competitive sport as an anabolic agent